Achieving Optimal Patient Outcomes After Frontal Sinus Endoscopy
Hossameldin Mosa Sharaf *
Otorhinolaryngology Department, Helwan University, Egypt and Otorhinolaryngology Department, Almoosa Specialist Hospital, KSA.
Mohamed Gamil Hamid
Otorhinolaryngology Department, Helwan University, Egypt.
Ayman Fouad
Otorhinolaryngology Department, Almoosa Specialist Hospital, KSA and Otorhinolaryngology Department, Tanta University, Egypt.
Mohamed A. Alhussaini
Otorhinolaryngology Department, Almoosa Specialist Hospital, KSA and Otorhinolaryngology Department, Assiut University, Egypt.
Aly Ahmed Elgarem
Otorhinolaryngology Department, Cairo University, Egypt.
Ahmed Medhat El Shafei
Otorhinolaryngology Department, Helwan University, Egypt.
Khalid A AlYahya
Otorhinolaryngology- head and neck surgery, King Faisal university, KSA.
Abdullah A Alarfaj
Otorhinolaryngology- head and neck surgery, King Faisal university, KSA.
Mohamed Mahmoud Elsheikh
Otorhinolaryngology Department, Helwan University, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Aims: Evaluating the Role of Biodegradable Drug-Eluting Stents in Enhancing Outcomes after Frontal Endoscopic Sinus Surgery.
Study Design: Prospective case control study.
Place and Duration of Study: The Department of Otorhinolaryngology in Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia, and Helwan University Hospital (Badr Hospital), Egypt. From March 2025 to December 2025.
Methodology: A total of 42 adult participants were enrolled and randomly assigned to either the Propel stent group (n=21) or the control group (n=21). Participants were monitored for nine months through clinical and radiographic evaluations, focusing on outcomes such as patency of the ostium, presence of adhesions, and recurrence of polyps.
Results: After nine months, the Propel stent group exhibited significantly higher ostium patency rates compared to the controls. Additionally, lower rates of stenosis, retained secretions, adhesions, and polyp formation were observed in the Propel stent group.
Conclusion: Propel stents significantly enhance frontal sinus patency and reduce the occurrence of postoperative adhesions and polyp recurrence in comparison to non-drug-eluting stents.
Keywords: Functional endoscopic sinus surgery, biodegradable drug-eluting propel stents, frontal sinus